Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.76 |
| ▸ | LMNA | P02545 | 4/20 | 0.76 |
| ▸ | TSHR | P16473 | 5/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.72 |
| ▸ | POLB | P06746 | 3/20 | 0.72 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.68 |
| ▸ | HPGD | P15428 | 1/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.67 |
| ▸ | ELANE | P08246 | 1/20 | 0.67 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.67 |
| ▸ | GAA | P10253 | 1/20 | 0.65 |
| ▸ | RECQL | P46063 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 2/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.64 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.63 |
| ▸ | MAPT | P10636 | 2/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9575455 | 0.89 | KDM4E (0.80) | KDM4ELMNATSHRHSD17B10POLB | |
| SCHEMBL31730773 | 0.89 | KDM4E (0.80) | KDM4ELMNATSHRHSD17B10POLB | |
| SCHEMBL28441203 | 0.88 | LMNA (0.60) | KDM4ELMNATSHRHSD17B10POLB | |
| SCHEMBL14855680 | 0.86 | KDM4E (0.76) | KDM4ELMNATSHRHSD17B10POLB | |
| SCHEMBL22445033 | 0.86 | TSHR (0.74) | KDM4ELMNATSHRHSD17B10POLB | |
| SCHEMBL14855798 | 0.85 | SMN1; SMN2 (0.75) | KDM4ELMNATSHRHSD17B10POLB | |
| SCHEMBL9183126 | 0.84 | ELANE (0.74) | KDM4ELMNATSHRHSD17B10POLB | |
| SCHEMBL7367856 | 0.82 | LMNA (0.70) | KDM4ELMNATSHRHSD17B10POLB | |
| SCHEMBL14856210 | 0.82 | KDM4E (0.69) | KDM4ELMNATSHRHSD17B10POLB | |
| SCHEMBL14855679 | 0.80 | POLB (0.72) | KDM4ELMNATSHRHSD17B10POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2663311-A2 | PYRIMIDINONE DERIVATIVES AS FATTY ACID SYNTHASE INHIBITORS | GlaxoSmithKline LLC (US) | 2013-11-20 | — | — | EP | disclosed |
| US-20130303551-A1 | PYRIMIDINONE DERIVATIVES AS FATTY ACID SYNTHASE INHIBITORS | GLAXOSMITHKLINE LLC | 2013-11-14 | — | — | US | disclosed |
| US-20130303551-A1 | PYRIMIDINONE DERIVATIVES AS FATTY ACID SYNTHASE INHIBITORS | GLAXOSMITHKLINE LLC | 2013-11-14 | — | — | US | disclosed |
| US-20130303551-A1 | PYRIMIDINONE DERIVATIVES AS FATTY ACID SYNTHASE INHIBITORS | GLAXOSMITHKLINE LLC | 2013-11-14 | — | — | US | disclosed |
| WO-2012096928-A2 | PYRIMIDINONE DERIVATIVES AS FATTY ACID SYNTHASE INHIBITORS | GLAXOSMITHKLINE LLC (US) | 2012-07-19 | — | — | WO | disclosed |
| WO-2012096928-A2 | PYRIMIDINONE DERIVATIVES AS FATTY ACID SYNTHASE INHIBITORS | GLAXOSMITHKLINE LLC (US) | 2012-07-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130303551-A1 | PYRIMIDINONE DERIVATIVES AS FATTY ACID SYNTHASE INHIBITORS | FASN, FPGS, DHPS | KDM4E 1483/4885LMNA 3065/4885TSHR 3387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.